| Application no. and date | 17878604.2 (espacenet) (Federated) (European Patent Register), 20171208 | | Patent/reg. no. and date | DK/EP 3551189, 20231101 | | Publication date | 20191016 | | Priority no. and date | US 201662432353 P, 20161209, US 201762485281 P, 20170413 | | EP pub. no. and date |
EP 3551189 20191016 | | Effective date | | | Applicant/owner | Alexza Pharmaceuticals, Inc., 6550 Dumbarton Circle, Suite A
Fremont, CA 94555, US | | Applicant ref. no. | 169278 BT/JA | | Inventor | CASSELLA, James, 7 Little Point Street
Essex, Connecticut 06426, US,
GONG, Lily, 1411 Montego Drive
San Jose, California 95120, US,
KAMEMOTO, Edwin S., 585 Dory Lane
Redwood City, California 94065, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/5517 (2006.01) , A61K 31/573 (2006.01) , A61K 9/00 (2006.01) , A61P 25/08 (2006.01) | | Title | ALPRAZOLAM TIL ANVENDELSE VED BEHANDLING AF EPILEPSI | | Int. application no. | US2017065347 | | Int. publication no. | WO2018107045 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
